+919405117673
Salmeterol + Fluticasone Inhaler – Advanced Asthma & COPD Management | Global Exporter from India
Salmeterol + Fluticasone Inhaler is a combination therapy containing:

Salmeterol (Long-Acting Beta Agonist – LABA)

Fluticasone Propionate (Inhaled Corticosteroid – ICS)

This dual-action inhaler works by relaxing airway muscles and reducing inflammation, providing long-term control of respiratory conditions.

✔ Key Benefits:

Improves breathing and lung function

Prevents asthma attacks

Reduces airway inflammation

Effective maintenance therapy for COPD

✅ Usage

Treatment of Asthma

Management of Chronic Obstructive Pulmonary Disease (COPD)

Relief from Wheezing, Breathlessness & Chest Tightness

Long-term maintenance therapy

💉 Dosage

Adults & Children (as prescribed):1–2 inhalations twice daily

👉 Use regularly for best results. Not intended for sudden asthma attacks.

⚠️ Precautions

Not for acute asthma relief (use rescue inhaler instead)

Rinse mouth after use to prevent oral infections

Use cautiously in:

Heart disease

Diabetes

Thyroid disorders

Avoid abrupt discontinuation

Consult doctor during pregnancy & breastfeeding

🚨 Side Effects

Common side effects:

Throat irritation

Hoarseness

Oral fungal infection (thrush)

Headache

Tremors

Rare but serious:

Increased heart rate

Severe allergic reactions

Worsening breathing problems

👉 Seek medical help if severe side effects occur.

🌎 Why Choose Cordium Pharmaceuticals?

✔ Trusted Respiratory Medicine Exporter from India

✔ WHO-GMP Certified Manufacturing

✔ Fast Delivery to USA, UK, UAE, Canada, South Africa

✔ Bulk Supply for Importers & Distributors

✔ Competitive Pricing & High Quality Assurance

📦 Export Markets

We export Salmeterol + Fluticasone Inhalers to:

United States (USA)

United Kingdom (UK)

United Arab Emirates (UAE)

Canada

South Africa

Europe (Germany, France, Italy, Spain)

Major Cities: New York, London, Dubai

📞 Contact for Bulk Orders & Inquiry

📱 WhatsApp: +91-9405117673📧 Email: info@cordiumpharma.com

Apr 12th, 2026 6:43 PM

Keywords